High levels of circulating TNFR1 increase the risk of all-cause mortality and progression of renal disease in type 2 diabetic nephropathy

Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes

(2015) Meda E. Pavkov et al.   KIDNEY INTERNATIONAL

Soluble Tumor Necrosis Factor Receptor 1 and 2 Predict Outcomes in Advanced Chronic Kidney Disease: A Prospective Cohort Study

(2015) Nathalie Neirynck et al.   PLoS One

Association of Serum Concentration of TNFR1 With All-Cause Mortality in Patients With Type 2 Diabetes and Chronic Kidney Disease: Follow-up of the SURDIAGENE Cohort

(2014) Pierre-Jean Saulnier et al.   DIABETES CARE

Circulating TNF Receptor 2 is Closely Associated with the Kidney Function in Non-Diabetic Japanese Subjects

(2014) Tomoyuki Kurashina et al.   Journal of Atherosclerosis and Thrombosis

Valsartan slows the progression of diabetic nephropathy indb/dbmice via a reduction in podocyte injury, and renal oxidative stress and inflammation

(2013) Guangyu Zhou et al.   CLINICAL SCIENCE

Circulating TNF receptor 2 is associated with the development of chronic kidney disease in non-obese Japanese patients with type 2 diabetes

(2013) Yoshio Izumi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Effect of Dual Blockade of the Renin-Angiotensin System on the Progression of Type 2 Diabetic Nephropathy: A Randomized Trial

(2012) Gema Fernandez Juarez et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Circulating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes

(2012) T. Gohda et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes

(2012) M. A. Niewczas et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Passive immunization against tumour necrosis factor-alpha (TNF-α) and IL-lβ protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats

(2010) A. M. KARKAR et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy

(2008) Paula Vieitez et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM